Promyelocytes are a crucial stage in the maturation process of myeloid cells, which are a type of white blood cell. These cells undergo differentiation in the bone marrow, specifically in the granulopoiesis pathway, leading to the formation of mature granulocytes, such as neutrophils, basophils, and eosinophils. Characterized by a distinctive appearance with a large, round nucleus containing fine chromatin granules, promyelocytes represent an intermediate stage between myeloblasts and myelocytes in the myeloid lineage. During hematopoiesis, promyelocytes exhibit active protein synthesis, preparing for the subsequent stages of granulocyte development. Specific cytoplasmic granules begin to form, representing the early stages of granule maturation. Abnormalities in promyelocyte differentiation can lead to hematological disorders, including certain types of leukemia, where uncontrolled proliferation of immature cells disrupts normal blood cell production. Promyelocytes serve a vital role in the immune system, as mature granulocytes derived from these cells play essential roles in defending the body against infections and maintaining immune homeostasis. Understanding the characteristics and regulation of promyelocytes is crucial for unraveling the complexities of hematopoiesis and developing targeted therapies for associated diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy